Table 3.
Variables | Prevalence 0.09% |
---|---|
Women screened, n | 10 000 |
Women identified as HIV-1 positive | 9 |
Women receiving test results | 8.1 (91%)a |
Women receiving antiretroviral therapy (ARV) | 4.9 – 7.4 (60% – 90%)a |
Women submitted to elective cesarean | 3.0 – 4.1 (37% – 50%)a |
Cases of mother-to-child transmission (MCT) expected among women without intervention | 1.14 – 2.04 (14% – 25%)a |
Number of cases of mother-to-child transmission prevented with ARV | 0.59 (95% CI 0.49–0.64)b 1.59 (95% CI 1.32–1.71)b |
Number needed to screen (NNS) to prevent one case of infant HIV infection | 4,542 (95% CI 4,141–5,346)c 11,800 (95% CI 10,730–13,928)d |
MCT = Mother-to-Child Transmission
ARV = Antiretroviral Therapy
a values in parenthesis are from literature sources
b values obtained from the model
c NNS calculated from the combination of preventive measures: ARV (90% and cesarean section (50%)
d NNS calculated from the combination of preventive measures: ARV (60% and cesarean section (37%)